Markets市場

Zealand's Swinging Stock Maps the Weight-Loss Drug Market's Next Bet

Zealand, the biotech whose share price has become an informal gauge of sentiment across the weight-loss drug sector, is recording a visible shift in investor positioning. One of its experimental medicines has lost market…

By Marcus Cole·June 20, 2026·二〇二六年六月二十日·2 min read